Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1000895-53-3

Post Buying Request

1000895-53-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1000895-53-3 Usage

Description

5-(3,5-diMethoxyphenethyl)-1H-pyrazol-3-aMine, also known as 3C-E, is a potent psychoactive compound that belongs to the phenethylamine and amphetamine chemical classes. It is a derivative of the phenethylamine hallucinogen mescaline and functions as a selective serotonin receptor agonist. Known for its hallucinogenic properties, 3C-E induces altered states of consciousness, visual and auditory hallucinations, and changes in perception. Due to its potential for abuse and harm, it is considered a controlled substance in many countries, and research into its long-term effects on human health is limited.

Uses

Used in Research Applications:
5-(3,5-diMethoxyphenethyl)-1H-pyrazol-3-aMine is used as a research chemical for studying the effects of psychedelic substances on the human brain and their potential therapeutic applications. Its ability to act as a selective serotonin receptor agonist makes it a valuable tool for investigating the mechanisms underlying hallucinations and altered states of consciousness.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 5-(3,5-diMethoxyphenethyl)-1H-pyrazol-3-aMine may be used as a starting point for the development of new drugs with potential therapeutic benefits. Its unique mechanism of action as a selective serotonin receptor agonist could lead to the discovery of novel treatments for various mental health disorders.
Used in Forensic Toxicology:
5-(3,5-diMethoxyphenethyl)-1H-pyrazol-3-aMine is used in forensic toxicology for the identification and analysis of this controlled substance in cases of drug abuse or poisoning. Its detection in biological samples can provide crucial information for legal proceedings and help in understanding the scope of its misuse.
Used in Drug Policy and Regulation:
In the field of drug policy and regulation, 5-(3,5-diMethoxyphenethyl)-1H-pyrazol-3-aMine serves as a reference compound for the development and enforcement of laws and regulations surrounding the use and distribution of psychedelic substances. Understanding its properties and potential risks is essential for creating effective public health strategies and ensuring the safety of the population.

Check Digit Verification of cas no

The CAS Registry Mumber 1000895-53-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,8,9 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1000895-53:
(9*1)+(8*0)+(7*0)+(6*0)+(5*8)+(4*9)+(3*5)+(2*5)+(1*3)=113
113 % 10 = 3
So 1000895-53-3 is a valid CAS Registry Number.

1000895-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine

1.2 Other means of identification

Product number -
Other names QC-93

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1000895-53-3 SDS

1000895-53-3Relevant articles and documents

Pyrazole derivative for FGFR inhibitor and preparation method of pyrazole derivative

-

, (2021/03/06)

The invention provides a pyrazole derivative for an FGFR inhibitor and a preparation method of the pyrazole derivative. The invention specifically relates to an amide pyrazole compound serving as an FGFR irreversible inhibitor, and a preparation method and application thereof. The present invention provides a compound as shown in Formula I, or a pharmaceutically acceptable salt, or solvate, isotope substitute, prodrug, or metabolite thereof. The compound as shown in general formula I have FGFR inhibitory activity, and is capable of preventing or treating disorders associated with FGFR activityor expression, preferably such as cancer.

Method for preparing AZD4547, intermediate and preparation method of intermediate

-

, (2020/05/14)

The invention provides a method for preparing AZD-4547. The method comprises the following steps: (1) preparing a first intermediate 2-cyano-5-(3, 5-dimethoxyphenyl)-3-oxoethyl valerate; (2) preparinga second intermediate 5-[2-(3, 5-dimethoxyphenyl) ethyl]-1H-pyrazole-3-amine by taking the first intermediate as a raw material; and (3) in an alkali-containing organic solvent, carrying out a reaction on a third intermediate 4-((3S, 5R)-3, 5-dimethylpiperazinyl-1-yl) benzoyl chloride and the second intermediate to prepare the AZD-4547. The method has the advantages of accessible raw materials, simple technique, mild reaction conditions, convenient operation, high yield and low cost and can easily implement industrial production. The invention also provides an intermediate 2-cyano-5-(3, 5-dimethoxyphenyl)-3-oxoethyl valerate for preparing AZD-4547 and a preparation method thereof.

Synthetic process for 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine

-

Paragraph 0037-0040, (2018/10/19)

The invention belongs to the field of medicine chemical industries, and particularly relates to a new synthetic process for 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine of an AZD4547 key intermediate. The synthetic process comprises the following steps: using 2-(3,5-dimethoxyphenyl) ethylpropionate as a starting raw material, in the presence of a basic catalyst and an organic solvent, reacting with acetonitrile, enabling an obtained product to perform cyclization with hydrazine hydrate in the presence of concentrated sulfuric acid, to obtain a target product of the 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine. Compared with a current technology, the provided synthetic process for the 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine is capable of greatly shortening thereaction time, enabling the yield of the product to be higher, wherein a process of purifying the intermediate does not exist between two steps of the reactions, shortening a reaction period, and reducing the wastewater discharge, and suitable for the industrialized mass production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1000895-53-3